Overview

Efficacy and Safety Study of Norethindrone Acetate Transdermal Delivery System in Contraception

Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether NEA TDS is effective in the prevention of pregnancy. The safety of this product will also be evaluated.
Phase:
Phase 3
Details
Lead Sponsor:
Watson Pharmaceuticals
Treatments:
Norethindrone
Norethindrone Acetate